University of Saskatchewan: COVAC-2
Vaccine Type: Protein Subunit
Vaccine Trial & Approval Tracker
-
Phase 1
-
Phase 2
-
Phase 3
-
Approved
This vaccine has reached Phase 2 trials.
About Trial Phases
Phase 3:
0
Trials
There are no trials for this phase.
Approvals
This vaccine is not yet approved.
Registered Trials
-
NCT05209009
Phase 2
Uganda
Total Enrollment: 300
Official Trial Registration:
-
NCT04702178
Phase 1/2
Canada
Total Enrollment: 72
Official Trial Registration:
-
NCT05226702
Phase 1/2
Canada
Total Enrollment: 380
Official Trial Registration:
